Download Free Educational Strategies To Prevent Prehospital Delay In Patients At High Risk For Acute Myocardial Infarction Book in PDF and EPUB Free Download. You can read online Educational Strategies To Prevent Prehospital Delay In Patients At High Risk For Acute Myocardial Infarction and write the review.

Cardiac Nursing: A Companion to Braunwald's Heart Disease is the only comprehensive text available for cardiac nurses. This brand-new reference emphasizes both evidence-based practice and hands-on care in a high-tech, high-touch approach that meets the high-stakes needs of cardiac and critical care nurses. What's more, the book makes the material easily accessible by using clear language, straightforward text, and plenty of illustrations, lists, and tables. This book is the third in a series of companion texts for Braunwald's Heart Disease and the first specifically for nurses. - Authored by the widely published, well-known co-editors of The Journal of Cardiovascular Nursing--two leaders in cardiac nursing. - Endorsed by the authors of Braunwald's Heart Disease, including Eugene Braunwald, the physician considered by many to be the "father of modern cardiology." - Evidence-based Practice boxes highlight research-supported advances in knowledge and care practices. - Conundrum boxes helps readers hone their critical thinking skills by tackling tough questions for which there may be no easy answers. - Technology boxes keeps readers up to date with the latest technological advances. - Genetics boxes helps readers understand connections between genes and heart disease. - Pharmacology tables present important drug-related information at a glance. - A guide to cardiac abbreviations and acronyms gives nurses quick access to essential information.
Presents Healthy People 2010, an initiative of the Office of Disease Prevention and Health Promotion of the.
Outlines a comprehensive, nationwide health promotion & disease prevention agenda. Designed to serve as a roadmap for improving the health of all people in the U.S. during the first decade of the 21st century. The Healthy People Consortium -- an alliance of more than 350 national organizations & 250 State public health, mental health, substance abuse, & environmental agencies -- conducted three national meetings. The final Healthy People 2010 objectives were developed by experts from a variety of Federal agencies. Vol. I: Understanding & Improving Health; & Objectives for Improving Health. Vol. II: Objectives for Improving Health; & Tracking Healthy People 2010.
Effectively and efficiently diagnose and manage today's full range of clotting and bleeding disorders using clinical case studies that demonstrate real-world problems and solutions! For each condition examined, you'll review concise descriptions of its associated symptoms, along with laboratory findings, diagnosis, differential diagnosis, and treatment - all the clinical guidance you need - at your fingertips. It's the ideal real-life reference tool for busy physicians! A reader-friendly design, coupled with nearly 385 illustrations and at-a-glance tables - many new to this edition - equip you to quickly locate the guidance you need. Abundant laboratory protocols enable you to select and interpret lab tests more easily. A complete section on women's health issues helps you stay current in this evolving area. A new chapter on the impact of herbal medicines examines their effect on hemostasis and their interaction with other drugs. New coverage of hemostatic issues in traumatology, sepsis, interventional radiology, pulmonology, and cardiology allows you to master the latest advances.
Annotation Interventional cardiologists, general cardiologists, endocrinologists, diabetologists The World Health Organization has projected that the prevalence of diabetes will double over the next 22 years - from a current figure of 150 million to an estimated 300 million people by the year 2025. The health-care burden of diabetes is enormous, and effective strategies to combat the explosive rise in the global incidence and prevalence of diabetes are urgently needed. Furthermore, diabetic patients have a considerable risk for cardiovascular disease, with up to 80% of deaths in individuals with diabetes attributable to microvascular or macrovascular complications. This book provides a concise overview of the present state of the art relating to the impact of diabetes mellitus on cardiovascular disease and to emerging treatment strategies that are beginning to impact on the management of the cardiovascular complications of this debilitating condition.
Teleologically, the hemostatic mechanism is among The of Coronary Thrombosis and the most fundamental yet complex physiologic pro- in essence, represents a heartfelt gift of cesses in humans. Early scientists and physicians were knowledge from a dedicated group of scientists and fascinated by the blood's ability to remain in a liquid clinicians, who collectively have set out on a mission state only to clot in response to vascular injury. The to minimize the societal impact of"hemostasis in the cellular and noncellular components of normal wrong place. " The book is divided into four distinct hemostasis took centuries to discover, and the intrica- sections: Part 1, Scientific Principles, lays down the cies of their delicate interactions are still being unrav- supporting foundation; Part 2, Clinical Application eled today. As is so often the case, an in-depth of Scientific Principles, places the knowledge base in appreciation of physiologic hemostasis, representing a a working perspective, directly applying science to basic life-sustaining sequence of events, paved the patient care; Part 3, New Dimensions, provides a way for understanding abnormal hemostasis or glimpse of tomorrow. Steering the field clear of se- pathologic thrombosis. Aristotle, Malpighi, and proclaimed victory and the dangers of complacency as Osier, representing but a few of the founding fathers we move into the 21st century, Part 4, Evolution of in the field, would undoubtedly be honored to see Thrombocardiology, focuses on laboratory standards, their observations form the template for lifesaving clinical trials, and drugs in development.